Punch, surgical, biopsy
Australia TGA ARTG Registered Device · GlaxoSmithKline Australia Pty Ltd · GSK Consumer Healthcare (GMDT) · Class IIa · Started June 18, 2019
Good Name: GlaxoSmithKline Australia Pty Ltd - Punch, surgical, biopsy
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 18, 2019
- Effective Date
- June 18, 2019
- Country
- Ireland
- Address
- Clocherane Youghal Road, Dungarvan, Co Waterford
Surgical instrument with sharpened, round/hollow blade made of stainless steel used for dermatology diagnostic, therapeutic and scientific purposes.
Access comprehensive regulatory information for Punch, surgical, biopsy in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by GlaxoSmithKline Australia Pty Ltd, manufactured by GSK Consumer Healthcare (GMDT) in Ireland. The device registration started on June 18, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.